X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (938) 938
Publication (35) 35
Magazine Article (10) 10
Newsletter (8) 8
Newspaper Article (7) 7
Book Review (4) 4
Book / eBook (2) 2
Book Chapter (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (739) 739
expectorants - administration & dosage (480) 480
male (411) 411
expectorants - therapeutic use (398) 398
female (329) 329
adult (237) 237
index medicus (234) 234
animals (196) 196
middle aged (180) 180
expectorants - pharmacology (155) 155
administration, inhalation (147) 147
pharmacology & pharmacy (146) 146
respiratory system (135) 135
child (134) 134
aged (132) 132
treatment outcome (129) 129
adolescent (113) 113
administration, oral (112) 112
expectorants (110) 110
expectorants - adverse effects (109) 109
aerosols (94) 94
cystic fibrosis - drug therapy (89) 89
acetylcysteine - administration & dosage (88) 88
child, preschool (84) 84
double-blind method (81) 81
chronic disease (79) 79
anti-bacterial agents - therapeutic use (75) 75
cystic fibrosis (74) 74
pulmonary disease, chronic obstructive - drug therapy (74) 74
bronchitis - drug therapy (72) 72
cough - drug therapy (70) 70
rats (70) 70
drug therapy, combination (69) 69
n-acetylcysteine (67) 67
bronchodilator agents - therapeutic use (66) 66
anti-bacterial agents - administration & dosage (64) 64
bronchodilator agents - administration & dosage (63) 63
time factors (62) 62
deoxyribonuclease i - administration & dosage (59) 59
expectorants - pharmacokinetics (59) 59
ambroxol - administration & dosage (58) 58
deoxyribonuclease i - therapeutic use (57) 57
infant (56) 56
pediatrics (55) 55
recombinant proteins - therapeutic use (55) 55
acetylcysteine - therapeutic use (54) 54
clinical trials as topic (53) 53
drug combinations (53) 53
mice (53) 53
care and treatment (52) 52
drug therapy (52) 52
asthma - drug therapy (50) 50
medicine, general & internal (48) 48
mucus (48) 48
nebulizers and vaporizers (48) 48
recombinant proteins - administration & dosage (47) 47
research (47) 47
sputum (47) 47
acetylcysteine (45) 45
acute disease (45) 45
inflammation (44) 44
dosage and administration (43) 43
acetylcysteine - pharmacology (42) 42
ambroxol (42) 42
analysis (42) 42
cough (42) 42
mucociliary clearance - drug effects (41) 41
chronic obstructive pulmonary disease (39) 39
adrenal cortex hormones - administration & dosage (38) 38
anti-inflammatory agents - therapeutic use (38) 38
cystic fibrosis - physiopathology (38) 38
dose-response relationship, drug (38) 38
obstructive pulmonary-disease (38) 38
children (37) 37
drug administration schedule (37) 37
health aspects (37) 37
ambroxol - therapeutic use (36) 36
respiratory function tests (36) 36
sputum - drug effects (36) 36
antitussive agents - therapeutic use (34) 34
double-blind (34) 34
expectorant (34) 34
recombinant human dnase (34) 34
adrenal cortex hormones - therapeutic use (33) 33
lung - drug effects (33) 33
respiratory therapy (33) 33
anti-inflammatory agents - administration & dosage (32) 32
antitussive agents - administration & dosage (32) 32
lung - physiopathology (32) 32
respiratory tract infections - drug therapy (32) 32
surgery (32) 32
expectorants - chemistry (30) 30
prospective studies (30) 30
rabbits (30) 30
mucociliary clearance (29) 29
pulmonary disease, chronic obstructive - physiopathology (29) 29
chronic-bronchitis (28) 28
copd (28) 28
efficacy (28) 28
randomized controlled trials as topic (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (732) 732
German (60) 60
Russian (50) 50
French (34) 34
Chinese (17) 17
Italian (15) 15
Polish (13) 13
Spanish (13) 13
Japanese (9) 9
Dutch (5) 5
Danish (4) 4
Czech (3) 3
Turkish (3) 3
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Korean (1) 1
Portuguese (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 11/2013, Volume 85, Issue 3, pp. 604 - 613
In a number of pulmonary diseases, patients may develop abnormally viscous mucus reducing drug efficacy. To increase budesonide diffusion within lung fluid, we... 
Dry powder inhaler | Budesonide | Nanoporous microparticles | Ambroxol | Calu-3 cells | Andersen cascade impactor | PARTICLES | COMBINATION THERAPY | BARRIER | INHALED CORTICOSTEROIDS | DRY POWDER INHALATION | FORMULATION | IN-VITRO | PHARMACOLOGY & PHARMACY | CELL-CULTURE | Cell Line | Dry Powder Inhalers | Epithelial Cells - metabolism | Bronchodilator Agents - administration & dosage | Humans | Administration, Inhalation | Ambroxol - pharmacokinetics | Permeability | Chemistry, Pharmaceutical | Drug Delivery Systems | Microspheres | Expectorants - pharmacokinetics | Bronchodilator Agents - pharmacokinetics | Expectorants - administration & dosage | Ambroxol - administration & dosage | Drug Compounding | Lung - metabolism | Budesonide - administration & dosage | Porosity | Respiratory Mucosa - metabolism | Diffusion | Bronchi - cytology | Budesonide - pharmacokinetics | Drugs | Respiratory agents | Drug delivery systems | Vehicles | Ambroxol/pharmacokinetics | Expectorants/administration & dosage | Life Sciences | Budesonide/administration & dosage | Expectorants/pharmacokinetics | Budesonide/pharmacokinetics | Bronchodilator Agents/administration & dosage | Pharmaceutical sciences | Administration | Epithelial Cells/metabolism | Lung/metabolism | Pharmaceutical | Inhalation | Chemistry | Bronchodilator Agents/pharmacokinetics | Bronchi/cytology | Respiratory Mucosa/metabolism | Ambroxol/administration & dosage
Journal Article
Journal Article
Journal Article
Journal of Cystic Fibrosis, ISSN 1569-1993, 2006, Volume 5, Issue 4, pp. 205 - 213
Therapy of chronic respiratory diseases often involves inhalation therapy with nebulizers. Patients often attempt to shorten the time consuming administration... 
Review | Compatibility | Inhalation solutions | Nebulizer | SOLUTION ADMIXTURES | RESPIRATORY SYSTEM | inhalation solutions | review | PHYSICAL-CHEMICAL COMPATIBILITY | nebulizer | compatibility | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Respiratory Therapy - methods | Tobramycin - pharmacology | Tobramycin - administration & dosage | Colistin - pharmacology | Cromolyn Sodium - pharmacology | Deoxyribonuclease I - pharmacology | Albuterol - administration & dosage | Acetylcysteine - administration & dosage | Drug Therapy, Combination | Anti-Asthmatic Agents - pharmacology | Administration, Inhalation | Colistin - administration & dosage | Cromolyn Sodium - administration & dosage | Bronchodilator Agents - pharmacology | Deoxyribonuclease I - administration & dosage | Asthma - drug therapy | Ipratropium - pharmacology | Budesonide - pharmacology | Ipratropium - administration & dosage | Expectorants - administration & dosage | Acetylcysteine - pharmacology | Anti-Bacterial Agents - pharmacology | Expectorants - pharmacology | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Nebulizers and Vaporizers | Cromolyn sodium | Surface active agents | Antibacterial agents | Lung diseases
Journal Article
Current Opinion in Pharmacology, ISSN 1471-4892, 06/2018, Volume 40, pp. 39 - 45
Journal Article
Thorax, ISSN 0040-6376, 12/2014, Volume 69, Issue 12, pp. 1073 - 1079
Journal Article
Journal Article